France’s Sanofi to buy immuno-oncology specialist Synthorx

PARIS: French pharmaceutical giant Sanofi said on Monday it had agreed to buy US biotech firm Synthorx to boost its immuno-oncology portfolio. Sanofi said it will pay $2.5 billion... Read more »

France’s Sanofi to buy Synthorx for $2.5 bln

French pharmaceutical company Sanofi has offered to buy all of the outstanding shares of Synthorx common stock for $68 per share in cash, worth around $2.5 billion as it... Read more »